サマリー

びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬の世界市場2022-2026年
Technavioは、びまん性大B細胞リンパ腫（DLBCL）治療薬市場を監視しており、2022-2026年の間に17億9000万ドル、予測期間中に7.71％のCAGRで進行して成長することが予測されるとしています。当レポートでは、びまん性大B細胞リンパ腫（DLBCL）治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、高齢者人口の増加、DLBCLの発症率の増加、再発または難治性のDLBCL患者に対する治療薬の承認の増加によって牽引されています。
びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場の分析には、製品セグメントと地理的な状況が含まれます。
Technavioのびまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場は、以下のようにセグメント化されています。
製品別
- 低分子化合物
- 生物学的製剤
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域（ROW）
本調査では、技術の進歩が今後数年間のびまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、患者支援プログラムの増加や戦略的提携は、市場の大規模な需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場に関する当レポートは、以下の分野を対象としています。
- びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場のサイジング
- びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場予測
- びまん性大細胞型リンパ腫（DLBCL）治療薬市場の産業分析
Technavioの堅牢なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、ADC Therapeutics SA、Amgen Inc、Bayer AG、BeiGene Ltd、Bristol Myers Squibb Co. 、Celltrion Healthcare Co.ホフマン・ラ・ロシュ社、ギリアド・サイエンシズ社、グラクソ・スミスクライン社、メルク・アンド・カンパニー社、ノバルティス社、アムジェン社、ベイジーン社、ブリストル・マイヤーズスクイブ社、セルトリオン・ヘルスケア社、CTIバイオファーマ社、エリテク・ファーマ社、F．ギリアド・サイエンシズ、グラクソ・スミスクライン、メルク、ノバルティス、ファイザー、リジェネロン、セーゲン、スペクトラム、シンバイオ、武田薬品工業、テバ・ファーマシューティカルズLtd.、Teva Pharmaceutical Industries Ltd.、TG Therapeutics Inc.の7社です。また、びまん性大細胞型B細胞リンパ腫（DLBCL）治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題についての情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/diffuse-large-b-cell-lymphoma-DLBCL-therapeutics-market-industry-analysis](https://www.technavio.com/report/diffuse-large-b-cell-lymphoma-dlbcl-therapeutics-market-industry-analysis)
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法によって、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Small molecules - Market size and forecast 2021-2026
o Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
o 5.4 Biologics - Market size and forecast 2021-2026
o Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Product
o Exhibit 36: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 85: AbbVie Inc. - Overview
o Exhibit 86: AbbVie Inc. - Product / Service
o Exhibit 87: AbbVie Inc. - Key offerings
o 10.4 Amgen Inc.
o Exhibit 88: Amgen Inc. - Overview
o Exhibit 89: Amgen Inc. - Product / Service
o Exhibit 90: Amgen Inc. - Key offerings
o 10.5 Bayer AG
o Exhibit 91: Bayer AG - Overview
o Exhibit 92: Bayer AG - Business segments
o Exhibit 93: Bayer AG - Key offerings
o Exhibit 94: Bayer AG - Segment focus
o 10.6 BeiGene Ltd.
o Exhibit 95: BeiGene Ltd. - Overview
o Exhibit 96: BeiGene Ltd. - Business segments
o Exhibit 97: BeiGene Ltd. - Key offerings
o Exhibit 98: BeiGene Ltd. - Segment focus
o 10.7 Erytech PharmaSA
o Exhibit 99: Erytech PharmaSA - Overview
o Exhibit 100: Erytech PharmaSA - Product / Service
o Exhibit 101: Erytech PharmaSA - Key offerings
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 102: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 103: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 104: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 105: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 106: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 Merck and Co. Inc.
o Exhibit 107: Merck and Co. Inc. - Overview
o Exhibit 108: Merck and Co. Inc. - Business segments
o Exhibit 109: Merck and Co. Inc. - Key news
o Exhibit 110: Merck and Co. Inc. - Key offerings
o Exhibit 111: Merck and Co. Inc. - Segment focus
o 10.10 Novartis AG
o Exhibit 112: Novartis AG - Overview
o Exhibit 113: Novartis AG - Business segments
o Exhibit 114: Novartis AG - Key offerings
o Exhibit 115: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 116: Pfizer Inc. - Overview
o Exhibit 117: Pfizer Inc. - Product / Service
o Exhibit 118: Pfizer Inc. - Key news
o Exhibit 119: Pfizer Inc. - Key offerings
o 10.12 Spectrum Pharmaceuticals Inc.
o Exhibit 120: Spectrum Pharmaceuticals Inc. - Overview
o Exhibit 121: Spectrum Pharmaceuticals Inc. - Product / Service
o Exhibit 122: Spectrum Pharmaceuticals Inc. - Key news
o Exhibit 123: Spectrum Pharmaceuticals Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 124: Inclusions checklist
o Exhibit 125: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 126: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 127: Research methodology
o Exhibit 128: Validation techniques employed for market sizing
o Exhibit 129: Information sources
o 11.5 List of abbreviations
o Exhibit 130: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AbbVie Inc. - Overview
Exhibits86: AbbVie Inc. - Product / Service
Exhibits87: AbbVie Inc. - Key offerings
Exhibits88: Amgen Inc. - Overview
Exhibits89: Amgen Inc. - Product / Service
Exhibits90: Amgen Inc. - Key offerings
Exhibits91: Bayer AG - Overview
Exhibits92: Bayer AG - Business segments
Exhibits93: Bayer AG - Key offerings
Exhibits94: Bayer AG - Segment focus
Exhibits95: BeiGene Ltd. - Overview
Exhibits96: BeiGene Ltd. - Business segments
Exhibits97: BeiGene Ltd. - Key offerings
Exhibits98: BeiGene Ltd. - Segment focus
Exhibits99: Erytech PharmaSA - Overview
Exhibits100: Erytech PharmaSA - Product / Service
Exhibits101: Erytech PharmaSA - Key offerings
Exhibits102: F. Hoffmann La Roche Ltd. - Overview
Exhibits103: F. Hoffmann La Roche Ltd. - Business segments
Exhibits104: F. Hoffmann La Roche Ltd. - Key news
Exhibits105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits106: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits107: Merck and Co. Inc. - Overview
Exhibits108: Merck and Co. Inc. - Business segments
Exhibits109: Merck and Co. Inc. - Key news
Exhibits110: Merck and Co. Inc. - Key offerings
Exhibits111: Merck and Co. Inc. - Segment focus
Exhibits112: Novartis AG - Overview
Exhibits113: Novartis AG - Business segments
Exhibits114: Novartis AG - Key offerings
Exhibits115: Novartis AG - Segment focus
Exhibits116: Pfizer Inc. - Overview
Exhibits117: Pfizer Inc. - Product / Service
Exhibits118: Pfizer Inc. - Key news
Exhibits119: Pfizer Inc. - Key offerings
Exhibits120: Spectrum Pharmaceuticals Inc. - Overview
Exhibits121: Spectrum Pharmaceuticals Inc. - Product / Service
Exhibits122: Spectrum Pharmaceuticals Inc. - Key news
Exhibits123: Spectrum Pharmaceuticals Inc. - Key offerings
Exhibits124: Inclusions checklist
Exhibits125: Exclusions checklist
Exhibits126: Currency conversion rates for US$
Exhibits127: Research methodology
Exhibits128: Validation techniques employed for market sizing
Exhibits129: Information sources
Exhibits130: List of abbreviations